EB
Therapeutic Areas
Richter Gedeon Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cariprazine (Vraylar) | Major Depressive Disorder (adjunctive) | Phase III / Filed |
| Fezolinetant (Veoza) | Moderate to Severe Vasomotor Symptoms due to Menopause | Phase III / Filed |
| Biosimilar Adalimumab | Chronic Inflammatory Diseases (e.g., Rheumatoid Arthritis) | Phase III / Filed |
| Biosimilar Denosumab | Osteoporosis | Phase III |
| Novel CNS Compound | Undisclosed CNS Disorder | Phase II |
| Next-gen Women's Health Product | Undisclosed Gynecological Condition | Phase II |